EUVIMEDEUVIMED entdecken
Crossref

Piezocatalytic Sulfonation Enables Nongenetic Competition Therapy for Colorectal Cancer

Jieyun Shi, Jiyue Wu, Zhenhua Wang, Chaochao Wang, Yun Meng, Hao Chen, Tianlei Ying, Peiran Zhao, Yang Chen, Minbiao Ji, Jinghan Wang, Yelin Wu und 1 weitere

Journal of the American Chemical Society · 19.11.2026

DOI: 10.1021/jacs.6c20155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 19.11.2026. Verfasst von Jieyun Shi und 12 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Gefördert von: China Association for Science and Technology, Key Programme, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irreversible post-translational modifications provide a potential means to impose persistent changes in protein function, yet their controlled generation inside living cells remains challenging. Here, we develop an ultrasound-responsive potassium sodium niobate–gold (KNN@Au) piezoelectric nanoheterojunction functionalized with hyaluronic acid (KNN@Au-HA) to enable in situ terminal protein sulfonation. Under ultrasound excitation, the dynamic modulation of KNN polarization generates a piezo-potential that facilitates interfacial charge separation and electron transfer, promoting the single-electron reduction of O2 to •O2–. Meanwhile, Au–S coordination positions thiol substrates in close proximity to the catalytic surface, facilitating the subsequent multistep oxidation of cysteine thiols to the terminal −SO3H state. Using this platform, we identify ribosomal protein RPL32 as a functionally relevant sulfonation target and resolve sulfonation at Cys96 by mass spectrometry. This modification disrupts ribosomal proteostasis, induces NRF2 nuclear translocation and stress signaling, and converts colorectal cancer cells into a competitive “loser” state that undergoes neighbor-dependent apoptotic elimination. In HCT116 xenograft-bearing mice, ultrasound-activated KNN@Au-HA suppresses colorectal tumor growth; analysis of patient-derived single-cell transcriptomic data reveals RPL32 upregulation as a hallmark of the malignant “winner” state, establishing a functional match between this competition therapy and colorectal cancer. Together, these findings demonstrate that piezocatalytic protein modification can chemically reprogram cellular competitive fitness without genome editing, providing a proof of concept for nongenetic competition therapy against cancer.

Förderung

  • China Association for Science and Technology
  • Key Programme
  • National Natural Science Foundation of China
  • Shanghai Pudong New Area Health Commission

Zitieren

APA

Shi, J., Wu, J., Wang, Z., Wang, C., Meng, Y., Chen, H., Ying, T., Zhao, P., Chen, Y., Ji, M., Wang, J., Wu, Y., & Bu, W. (2026). Piezocatalytic Sulfonation Enables Nongenetic Competition Therapy for Colorectal Cancer. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.6c20155

Vancouver

Shi J, Wu J, Wang Z, Wang C, Meng Y, Chen H, et al. Piezocatalytic Sulfonation Enables Nongenetic Competition Therapy for Colorectal Cancer. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.6c20155

BibTeX
@article{Shi2026,
  author = {Shi, Jieyun and Wu, Jiyue and Wang, Zhenhua and Wang, Chaochao and Meng, Yun and Chen, Hao and Ying, Tianlei and Zhao, Peiran and Chen, Yang and Ji, Minbiao and Wang, Jinghan and Wu, Yelin and Bu, Wenbo},
  title = {Piezocatalytic Sulfonation Enables Nongenetic Competition Therapy for Colorectal Cancer},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  doi = {10.1021/jacs.6c20155}
}
Kostenlos starten →